Causality is the question of whether the drug caused the event. In drug safety it is an assessment, not a proof, and more than one person makes it.
- What counts. ICH E2A: the expression "reasonable causal relationship" means there are facts (evidence) or arguments to suggest a causal relationship. 21 CFR 312.32 says the same for US trials: a suspected adverse reaction is one where there is a reasonable possibility the drug caused it, and "reasonable possibility" means there is evidence to suggest a causal relationship.
- Clinical trials. E2A requires a causality assessment for every clinical investigation case, and a case judged related by either the reporting health care professional or the sponsor qualifies as an adverse drug reaction for reporting.
- Spontaneous reports. For reporting purposes, a spontaneous report usually implies causality (E2A). E2B(R3) says the same: when the relationship is unstated, a suspected causal relationship is implied, and the relatedness elements are left blank unless local rules ask for them.
- Where it goes. E2B(R3) G.k.9.i.2.r records each assessment with its source (r.1, for example the reporter or the company), its method (r.2, for example global introspection, an algorithm or a Bayesian calculation) and its result (r.3). The reporter's and the company's assessments sit side by side; one does not replace the other. The company can explain its view in the sender's comments (H.4).